These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 26349626)

  • 1. Development of N-hydroxybenzamide derivatives with indole-containing cap group as histone deacetylases inhibitors.
    Li X; Wu J; Li X; Mu W; Liu X; Jin Y; Xu W; Zhang Y
    Bioorg Med Chem; 2015 Oct; 23(19):6258-70. PubMed ID: 26349626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure optimization and preliminary bioactivity evaluation of N-hydroxybenzamide-based HDAC inhibitors with Y-shaped cap.
    Yu C; He F; Qu Y; Zhang Q; Lv J; Zhang X; Xu A; Miao P; Wu J
    Bioorg Med Chem; 2018 May; 26(8):1859-1868. PubMed ID: 29500131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of 3-hydroxycinnamamide-based HDAC inhibitors with potent in vitro and in vivo anti-tumor activity.
    Li X; Hou J; Li X; Jiang Y; Liu X; Mu W; Jin Y; Zhang Y; Xu W
    Eur J Med Chem; 2015 Jan; 89():628-37. PubMed ID: 25462271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, synthesis and biological evaluation of quinoline derivatives as HDAC class I inhibitors.
    Chen C; Hou X; Wang G; Pan W; Yang X; Zhang Y; Fang H
    Eur J Med Chem; 2017 Jun; 133():11-23. PubMed ID: 28371677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of novel ferulic acid derivatives as potent histone deacetylase inhibitors.
    Wang F; Lu W; Zhang T; Dong J; Gao H; Li P; Wang S; Zhang J
    Bioorg Med Chem; 2013 Nov; 21(22):6973-80. PubMed ID: 24095016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and biological evaluation of indeno[1,2-d]thiazole derivatives as potent histone deacetylase inhibitors.
    Zhou M; Ning C; Liu R; He Y; Yu N
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3200-3. PubMed ID: 23639537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and preliminary bioactivity evaluation of N
    Wang X; Li X; Li J; Hou J; Qu Y; Yu C; He F; Xu W; Wu J
    Chem Biol Drug Des; 2017 Jan; 89(1):38-46. PubMed ID: 27416889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Search for novel histone deacetylase inhibitors. Part II: design and synthesis of novel isoferulic acid derivatives.
    Lu W; Wang F; Zhang T; Dong J; Gao H; Su P; Shi Y; Zhang J
    Bioorg Med Chem; 2014 May; 22(9):2707-13. PubMed ID: 24702857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and preliminary bioactivity evaluations of substituted quinoline hydroxamic acid derivatives as novel histone deacetylase (HDAC) inhibitors.
    Wang L; Hou X; Fu H; Pan X; Xu W; Tang W; Fang H
    Bioorg Med Chem; 2015 Aug; 23(15):4364-4374. PubMed ID: 26149591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of histone deacetylase inhibitors with benzoylhydrazide scaffold that selectively inhibit class I histone deacetylases.
    Wang Y; Stowe RL; Pinello CE; Tian G; Madoux F; Li D; Zhao LY; Li JL; Wang Y; Wang Y; Ma H; Hodder P; Roush WR; Liao D
    Chem Biol; 2015 Feb; 22(2):273-84. PubMed ID: 25699604
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved antiproliferative activity of 1,3,4-thiadiazole-containing histone deacetylase (HDAC) inhibitors by introduction of the heteroaromatic surface recognition motif.
    Guan P; Wang L; Hou X; Wan Y; Xu W; Tang W; Fang H
    Bioorg Med Chem; 2014 Nov; 22(21):5766-75. PubMed ID: 25311567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A cyclodextrin-capped histone deacetylase inhibitor.
    Amin J; Puglisi A; Clarke J; Milton J; Wang M; Paranal RM; Bradner JE; Spencer J
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3346-8. PubMed ID: 23591111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis and bioevalution of novel benzamides derivatives as HDAC inhibitors.
    Li Y; Zhou Y; Qian P; Wang Y; Jiang F; Yao Z; Hu W; Zhao Y; Li S
    Bioorg Med Chem Lett; 2013 Jan; 23(1):179-82. PubMed ID: 23206867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel N-hydroxyfurylacrylamide-based histone deacetylase (HDAC) inhibitors with branched CAP group (Part 2).
    Feng T; Wang H; Su H; Lu H; Yu L; Zhang X; Sun H; You Q
    Bioorg Med Chem; 2013 Sep; 21(17):5339-54. PubMed ID: 23820574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, synthesis and biological evaluation of saccharin-based N-hydroxybenzamides as histone deacetylases (HDACs) inhibitors.
    Fu H; Han L; Hou X; Dun Y; Wang L; Gong X; Fang H
    Bioorg Med Chem; 2015 Sep; 23(17):5774-81. PubMed ID: 26216016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, biological evaluation and molecular docking studies of 3-(1,3-diphenyl-1H-pyrazol-4-yl)-N-phenylacrylamide derivatives as inhibitors of HDAC activity.
    Li X; Liu JL; Yang XH; Lu X; Zhao TT; Gong HB; Zhu HL
    Bioorg Med Chem; 2012 Jul; 20(14):4430-6. PubMed ID: 22705022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis and activity evaluation of indole-based double - Branched HDAC1 inhibitors.
    Zhang Q; Lv J; He F; Yu C; Qu Y; Zhang X; Xu A; Wu J
    Bioorg Med Chem; 2019 Apr; 27(8):1595-1604. PubMed ID: 30879863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory selectivity among class I HDACs has a major impact on inflammatory gene expression in macrophages.
    Cao F; Zwinderman MRH; van Merkerk R; Ettema PE; Quax WJ; Dekker FJ
    Eur J Med Chem; 2019 Sep; 177():457-466. PubMed ID: 31181405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery and preliminary evaluation of 2-aminobenzamide and hydroxamate derivatives containing 1,2,4-oxadiazole moiety as potent histone deacetylase inhibitors.
    Cai J; Wei H; Hong KH; Wu X; Cao M; Zong X; Li L; Sun C; Chen J; Ji M
    Eur J Med Chem; 2015; 96():1-13. PubMed ID: 25874326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of novel HDAC inhibitors on urothelial carcinoma cells.
    Kaletsch A; Pinkerneil M; Hoffmann MJ; Jaguva Vasudevan AA; Wang C; Hansen FK; Wiek C; Hanenberg H; Gertzen C; Gohlke H; Kassack MU; Kurz T; Schulz WA; Niegisch G
    Clin Epigenetics; 2018 Jul; 10(1):100. PubMed ID: 30064501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.